Published By : 12 Jan 2016 | Published By : QYRESEARCH
Atopic dermatitis is a type of skin disorder or a kind of chronic eczematous skin disease. Atopic dermatitis is commonly known by eczema or atopic eczema. In this, the skin becomes sensitive, inflamed, itchy, and very dry. If the person or an infant suffering from atopic dermatitis keeps on scratching the affected area, then it results in swelling, scaling, redness, crusting, weeping, and cracking. This condition is mostly inherited or can also be a result of environmental conditions. Many people who live in extreme dry climatic condition are every much prone to develop atopic dermatitis.
As atopic dermatitis skin disorder can affect a person of any age; however, in most of the cases it affects young children and infants. Some of the patients incline to face a protracted course with some ups and downs. Whereas, in some cases, there is a certain time period, when the skin disease is at the worst stage, called as flares or exacerbations that are further followed by time-periods during which the skin r clears up entirely, or improves to a certain extent. Many infants suffering from atopic dermatitis condition enter into a long-lasting remission of this disease as they get older, even though their skin may continue to remain quite dry.
According to the statistics presented by the National Eczema Association, in recent years, the number of patients with atopic dermatitis have increased tremendously. In the U.S., around 10% to 20% infants are suffering from this condition as of now. Hence, many pharmaceutical companies are spending enormous amount in research and development department so as to introduce new products in the market for treating the condition of atopic dermatitis across the globe. Some of the key players operating in this market are Regeneron Pharmaceuticals, Inc., Anacor Pharmaceuticals Inc., Meda AB., and Astellas Pharma. These companies are focusing on product innovation, which is expected to be the key factor to boost the demand of this market, However, the intake of new drugs can also lead to numerous side effects that can hamper the growth of the atopic dermatitis treatment market in the near future.